73 related articles for article (PubMed ID: 3583496)
1. Normal and slow-release formulations of bezafibrate: a comparative pharmacokinetic study in man.
Gandini R; Assereto R; Castoldi D; Cunietti E; Garanzelli P; Monzani W
Int J Clin Pharmacol Res; 1987; 7(2):149-55. PubMed ID: 3583496
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration].
Vens-Cappell B; Hilgenstock C; Gellert M; Kühle K; Reifferscheid I; Winckler P; Bührens KG
Arzneimittelforschung; 1993 Mar; 43(3):346-50. PubMed ID: 8489566
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of two oral bezafibrate preparations.
Cadorniga R; Herrero R; Pastoriza P; Molina IT; Gutierrez JA; Iglesias JJ
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():261-7. PubMed ID: 1820889
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 2. Multiple-dose administration and chronopharmacokinetics].
Vens-Cappell B; Berndt P; Hilgenstock C; Kühle K; Reifferscheid I; Schütt S; Bührens KG
Arzneimittelforschung; 1993 Mar; 43(3):351-6. PubMed ID: 8489567
[TBL] [Abstract][Full Text] [Related]
5. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation.
Arancibia A; González G; Icarte A; Arancibia M; Arancibia P
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
Bareggi SR; Gambaro V; Valenti M; Benvenuti C
Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-dynamic study on different oral biperiden formulations in volunteers.
Hollmann M; Müller-Peltzer H; Greger G; Brode E; Perucca E; Grimaldi R; Crema A
Pharmacopsychiatry; 1987 Mar; 20(2):72-7. PubMed ID: 3588663
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
Reiz JL; Donnelly GA; Michalko K
Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
[TBL] [Abstract][Full Text] [Related]
13. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of terbutaline given in slow-release tablets.
Nyberg L; Kennedy BM
Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions.
Klotz U
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412
[TBL] [Abstract][Full Text] [Related]
16. In vivo performance of controlled release pellets of diltiazem HCl.
Nisarur-ur-Rahman ; K H Y; Jia Woei W
Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
[TBL] [Abstract][Full Text] [Related]
18. Dissolution kinetics of bezafibrate in two solid forms for oral administration.
Cadorniga R; Hernanez MT; Negro S; Burgos ML; Molina IT
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():371-8. PubMed ID: 1820910
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
[TBL] [Abstract][Full Text] [Related]
20. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study.
Park JY; Kim KA; Park PW; Suh KH; Lee GS
Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
